National Healthcare Properties (NASDAQ:NHP) Stock Picked Up by Analysts at Huntington

Equities research analysts at Huntington began coverage on shares of National Healthcare Properties (NASDAQ:NHP) in a report released on Wednesday, Zacks reports. The firm set a “strong-buy” rating on the stock.

A number of other equities research analysts have also recently commented on the company. Wells Fargo & Company decreased their price objective on National Healthcare Properties from $19.00 to $18.00 and set an “overweight” rating for the company in a research note on Monday, October 19th. Raymond James Financial initiated coverage on National Healthcare Properties in a report on Tuesday, October 13th. They issued an “outperform” rating and a $20.00 price objective for the company. Citizens Jmp increased their target price on National Healthcare Properties from $18.00 to $21.00 and gave the company a “market outperform” rating in a research note on Monday, August 10th. Robert W. Baird increased their target price on National Healthcare Properties from $17.00 to $18.00 and gave the company an “outperform” rating in a research note on Thursday, August 20th. Finally, Wall Street Zen upgraded National Healthcare Properties from a “hold” rating to a “buy” rating in a report on Saturday, October 10th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $18.30.

National Healthcare Properties Stock Performance

NHP opened at $15.21 on Wednesday. The stock’s fifty day simple moving average is $15.71. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.45. National Healthcare Properties has a 52 week low of $11.25 and a 52 week high of $17.46. The firm has a market cap of $1.11 billion and a price-to-earnings ratio of -117.00.

National Healthcare Properties (NASDAQ:NHP) last issued its earnings results on Wednesday, November 4th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.18 by $0.06. The company had revenue of $103.06 million during the quarter. National Healthcare Properties had a negative net margin of 3.35% and a negative return on equity of 1.62%. Equities analysts forecast that National Healthcare Properties will post 0.75 EPS for the current year.

Institutional Investors Weigh In On National Healthcare Properties

Several hedge funds have recently bought and sold shares of the company. Sumitomo Mitsui DS Asset Management Company Ltd bought a new position in shares of National Healthcare Properties during the third quarter worth $175,000. Copeland Capital Management LLC acquired a new position in shares of National Healthcare Properties in the 3rd quarter valued at $90,000. Envestnet Asset Management Inc. acquired a new position in shares of National Healthcare Properties in the 2nd quarter valued at $366,000. State Street Corp acquired a new position in shares of National Healthcare Properties in the 2nd quarter valued at $8,975,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of National Healthcare Properties in the 2nd quarter valued at $518,000.

About National Healthcare Properties

National Health Properties, Inc was a real estate investment trust that owned and leased healthcare-related properties in the United States. Its portfolio included healthcare facilities such as skilled nursing centers, assisted living communities, medical office buildings and other properties used by healthcare providers.

The company generally generated rental income through long-term leases with healthcare operators. Its business model focused on acquiring and managing income-producing healthcare real estate rather than directly providing medical or senior-care services.

National Health Properties was acquired by Ventas, Inc in 2015 and no longer operates as an independent publicly traded company.